Keywords: boehringer, ingelheim, reports, strong, sales, income, growth
Boehringer Ingelheim reports strong sales and income growth for 2004
Article | 18 April 2005
Privately-held German drugmaker Boehringer Ingelheim posted strong growth yet again for 2004, outpacing the market for the fifth consecutive year. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
